Literature DB >> 18308897

Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program.

L Matthews1, A Berry, V Ohanian, J Ohanian, H Garside, D Ray.   

Abstract

Many glucocorticoid (Gc) actions are of rapid onset and therefore require acute regulation of intracellular signaling cascades. Integration of diverse extracellular signals requires cross-talk between intracellular pathways, suggesting the existence of nodes for signal interaction, such as the specialized membrane microdomains caveolae. We have identified rapid Gc-dependent phosphorylation of caveolin, and protein kinase B (PKB)/Akt, in the lung epithelial cell line A549 and found this was dependent on src kinases. There was also activation of PKB downstream molecules glycogen synthase kinase-3beta, and mammalian target of rapamycin. Subcellular fractionation colocalized glucocorticoid receptor (GR) and c-src to caveolin-containing membrane fractions. Coimmunoprecipitation studies also identified interactions between GR and caveolin and suggested that the activation function 1 domain within the GR may serve to support an interaction between GR and caveolin. Disruption of lipid raft formation, impairment of caveolin function using dominant-negative caveolin, down-regulation of caveolin-1 using short hairpin RNA or complete ablation of caveolin-1 prevented Gc-induced activation of PKB. Loss of caveolin-1 also prevents Gc activation of glycogen synthase kinase-3beta and mammalian target of rapamycin. In contrast, caveolin interference/down-regulation had no effect on Gc transactivation. Functional analysis of caveolin-1 knockdown and knockout cells identified profound loss of Gc-mediated growth inhibition compared with controls, with a requirement for caveolin in order for Gc to regulate cell cycle progression. Therefore, disruption of caveolae leads to dissociation of Gc action, with impaired induction of PKB activation, and cell growth inhibition, but with negligible effects on Gc transactivation. These observations have implications for understanding the diverse physiological actions of Gc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308897      PMCID: PMC5419537          DOI: 10.1210/me.2007-0154

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  55 in total

Review 1.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

2.  Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.

Authors:  J Couet; M Sargiacomo; M P Lisanti
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

3.  Association of the heat shock protein hsp90 with steroid hormone receptors and tyrosine kinase oncogene products.

Authors:  A Ziemiecki; M G Catelli; I Joab; B Moncharmont
Journal:  Biochem Biophys Res Commun       Date:  1986-08-14       Impact factor: 3.575

4.  Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line.

Authors:  Alessio D'Alessio; Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Receptor-independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of phosphatidylinositol 3-kinase/protein kinase Akt pathway in short-term cardiovascular actions of dexamethasone at the nucleus tractus solitarii of the rat.

Authors:  Ling-Lin Wang; Chen-Chun Ou; Julie Y H Chan
Journal:  Mol Pharmacol       Date:  2004-11-02       Impact factor: 4.436

6.  Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells.

Authors:  F Chen; C S Watson; B Gametchu
Journal:  J Cell Biochem       Date:  1999-09-01       Impact factor: 4.429

7.  Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae.

Authors:  H P Kim; J Y Lee; J K Jeong; S W Bae; H K Lee; I Jo
Journal:  Biochem Biophys Res Commun       Date:  1999-09-16       Impact factor: 3.575

8.  Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.

Authors:  A Migliaccio; G Castoria; M Di Domenico; A de Falco; A Bilancio; M Lombardi; M V Barone; D Ametrano; M S Zannini; C Abbondanza; F Auricchio
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

9.  Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket.

Authors:  Y Morishima; P J Murphy; D P Li; E R Sanchez; W B Pratt
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

10.  Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.

Authors:  Helen Garside; Adam Stevens; Stuart Farrow; Claire Normand; Benoit Houle; Andy Berry; Barbara Maschera; David Ray
Journal:  J Biol Chem       Date:  2004-09-08       Impact factor: 5.157

View more
  40 in total

1.  Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.

Authors:  Ranmal Aloka Samarasinghe; Roberto Di Maio; Daniela Volonte; Ferruccio Galbiati; Marcia Lewis; Guillermo Romero; Donald B DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 3.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

4.  Thiazolidinediones are partial agonists for the glucocorticoid receptor.

Authors:  L Matthews; A Berry; M Tersigni; F D'Acquisto; A Ianaro; D Ray
Journal:  Endocrinology       Date:  2008-09-18       Impact factor: 4.736

Review 5.  Corticosteroids: way upstream.

Authors:  Therese Riedemann; Alexandre V Patchev; Kwangwook Cho; Osborne F X Almeida
Journal:  Mol Brain       Date:  2010-01-11       Impact factor: 4.041

Review 6.  Glucocorticoid receptors: finding the middle ground.

Authors:  Sofie J Desmet; Karolien De Bosscher
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

7.  Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.

Authors:  Melanie E Peffer; Uma R Chandran; Soumya Luthra; Daniela Volonte; Ferruccio Galbiati; Michael J Garabedian; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

8.  Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation.

Authors:  Lancelot Wehmeyer; Andrea Du Toit; Dirk M Lang; Janet P Hapgood
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 9.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

10.  Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth.

Authors:  Paula Sommer; Rachel L Cowen; Andrew Berry; Ann Cookson; Brian A Telfer; Kaye J Williams; Ian J Stratford; Paul Kay; Anne White; David W Ray
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.